XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q2)Dec 27, 2024 | (Q1)Sep 27, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 29, 2024 | (Q2)Dec 29, 2023 | (Q1)Sep 29, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 38.65%8.66M | -144.32%-4.34M | 47.24%33.72M | -28.66%11.44M | -8.80%6.23M | 757.83%6.25M | 1,508.33%9.8M | 375.45%22.9M | 1,571.47%16.04M | 210.58%6.83M |
Net income from continuing operations | 17.54%1.1M | -155.96%-2.77M | 5.33%11.25M | 8.86%7.49M | 16.18%3.9M | -46.88%935K | 18.20%-1.08M | -0.94%10.68M | -32.77%6.88M | 45.39%3.36M |
Operating gains losses | -15.38%-30K | -100.29%-9K | 97.87%-91K | -11,392.59%-3.1M | -32.35%-45K | 99.38%-26K | 7,440.48%3.08M | -36.40%-4.26M | 85.56%-27K | ---34K |
Depreciation and amortization | 30.02%3.3M | 30.14%3.24M | 6.65%9.98M | 2.52%2.48M | -7.34%2.47M | 19.24%2.54M | 16.26%2.49M | -1.97%9.36M | 8.65%2.42M | 15.78%2.67M |
Deferred tax | -101.09%-2K | -472.16%-361K | 11.67%-560K | -196.50%-799K | 88.52%-41K | -64.67%183K | 105.98%97K | 25.32%-634K | 55.06%828K | -57.27%-357K |
Other non cash items | ---- | ---- | -194.67%-320K | ---- | ---- | ---- | 16.18%-57K | 129.99%338K | ---- | ---- |
Change In working capital | -7.47%2.12M | -232.20%-5.47M | 126.19%10.01M | -9.53%4.48M | -322.19%-891K | 905.63%2.29M | 742.92%4.13M | 117.05%4.43M | 137.94%4.95M | 103.65%401K |
-Change in receivables | ---- | ---- | 213.67%9.54M | ---- | ---- | ---- | ---- | 0.14%-8.39M | ---- | ---- |
-Change in inventory | ---- | ---- | 318.73%6.02M | ---- | ---- | ---- | ---- | 85.18%-2.75M | ---- | ---- |
-Change in payables and accrued expense | ---- | ---- | -134.99%-5.92M | ---- | ---- | ---- | ---- | 113.03%16.92M | ---- | ---- |
-Change in other current assets | ---- | ---- | 328.78%2.04M | ---- | ---- | ---- | ---- | 115.45%476K | ---- | ---- |
-Change in other working capital | ---- | ---- | 8.97%-1.66M | ---- | ---- | ---- | ---- | 52.76%-1.83M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 38.65%8.66M | -144.32%-4.34M | 47.24%33.72M | -28.66%11.44M | -8.80%6.23M | 757.83%6.25M | 1,508.33%9.8M | 375.45%22.9M | 1,571.47%16.04M | 210.58%6.83M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -21.27%-2.46M | 25.32%-2.72M | -7,760.05%-32.07M | -2,327.97%-24.3M | 5.25%-2.09M | -144.98%-2.03M | -114.29%-3.65M | -106.91%-408K | 45.75%-1M | -646.62%-2.21M |
Net PPE purchase and sale | -59.05%-2.75M | 36.23%-2.35M | -1,075.03%-8.71M | 2.29%-1.11M | -7.66%-2.18M | -137.16%-1.73M | -65.10%-3.69M | -115.68%-741K | 44.77%-1.14M | -225.93%-2.02M |
Net business purchase and sale | ---- | ---- | ---23.18M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net other investing changes | 198.65%293K | -920.00%-369K | -155.26%-184K | -112.69%-17K | 145.70%85K | -99.33%-297K | -91.57%45K | -71.66%333K | -36.19%134K | -157.23%-186K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -21.27%-2.46M | 25.32%-2.72M | -7,760.05%-32.07M | -2,327.97%-24.3M | 5.25%-2.09M | -144.98%-2.03M | -114.29%-3.65M | -106.91%-408K | 45.75%-1M | -646.62%-2.21M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -8.68%-4.84M | 45.26%934K | 114.12%2.75M | 158.83%7.84M | -9.77%-1.27M | 22.49%-4.46M | -10.32%643K | -581.16%-19.51M | -659.51%-13.32M | -113.08%-1.16M |
Net issuance payments of debt | -9.85%-4.27M | 14.42%2.75M | 134.52%6.49M | 166.23%8.67M | 40.19%-692K | 28.73%-3.89M | 171.86%2.41M | -495.63%-18.81M | -604.47%-13.09M | -113.08%-1.16M |
Cash dividends paid | -1.07%-566K | ---570K | ---1.7M | ---576K | ---559K | ---560K | --0 | --0 | --0 | --0 |
Net other financing activities | 22.22%-7K | 29.15%-1.25M | -192.56%-2.05M | -7.63%-254K | ---19K | 96.95%-9K | -949.40%-1.76M | 0.14%-699K | -10.80%-236K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -8.68%-4.84M | 45.26%934K | 114.12%2.75M | 158.83%7.84M | -9.77%-1.27M | 22.49%-4.46M | -10.32%643K | -581.16%-19.51M | -659.51%-13.32M | -113.08%-1.16M |
Net cash flow | ||||||||||
Beginning cash position | -18.20%16.71M | 51.32%20.07M | 5.93%13.26M | 70.02%23.84M | 55.39%21.02M | 54.59%20.43M | 5.93%13.26M | 1.47%12.52M | 9.35%14.02M | 21.62%13.53M |
Current changes in cash | 673.42%1.36M | -190.18%-6.13M | 47.73%4.4M | -392.77%-5.02M | -17.28%2.86M | 54.16%-237K | 504.76%6.8M | 81.31%2.98M | 409.75%1.72M | 45.75%3.46M |
Effect of exchange rate changes | -360.72%-2.16M | 659.73%2.77M | 207.55%2.41M | 150.50%1.25M | 98.65%-40K | -0.12%830K | -84.62%365K | -53.01%-2.24M | -1,090.80%-2.48M | -341.07%-2.96M |
End cash Position | -24.33%15.91M | -18.20%16.71M | 51.32%20.07M | 51.32%20.07M | 70.02%23.84M | 55.39%21.02M | 54.59%20.43M | 5.93%13.26M | 5.93%13.26M | 9.35%14.02M |
Free cash flow | 30.18%5.88M | -209.72%-6.71M | 66.95%25.01M | -30.66%10.33M | -15.30%4.05M | 355.29%4.52M | 308.39%6.11M | 214.86%14.98M | 532.25%14.9M | 170.32%4.78M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |